Study shows efficacy and safety of OCT-guided strategy for percutaneous coronary intervention

Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding percutaneous coronary intervention (PCI), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma

Combining the anti-CD38 monoclonal antibody isatuximab (Sarclisa) with the standard backbone of bortezomib (Velcade), lenalidomide (Revlimid), and dexamethasone (VRd) significantly improved progression-free survival (PFS) in

June 15, 2024

New research underscores benefits of gender-affirming hormones, rebutting anti-trans claims

Anti-trans legislation and rhetoric frequently suggest that taking gender-affirming hormones is a big health risk. But at the annual meeting of the Endocrine Society last

June 23, 2023

Specification of the full-year forecast – Biotech Investments

Medios AG / Key word(s): Annual Results Medios AG: Specification of the full-year forecast 12-Dec-2024 / 13:27 CET/CEST Disclosure of an inside information acc. to

December 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.